Daniel O'Day plans sale of 115640 Gilead shares

Daniel O'Day filed to sell 115640 shares of Gilead common stock.

Accepted by SEC EDGAR 02/05/2026 - 04:05 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Daniel O'Day filed to sell 115640 shares of Gilead common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of 17346000.00 and 1240679623 Gilead shares outstanding.

The 115640 shares were acquired on 02/05/2026 via a stock option exercise from the issuer, paid in cash on the same date. Over the prior three months, O'Day sold additional Gilead common shares in four trades totaling 145640 shares for gross proceeds of 187627,? wait.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Daniel O'Day’s Form 144 filing for GILD disclose?

The filing discloses Daniel O'Day’s intent to sell 115640 shares of Gilead common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an indicated aggregate market value of 17346000.00 and 1240679623 Gilead shares reported as outstanding.

How many Gilead (GILD) shares does Daniel O'Day plan to sell?

Daniel O'Day plans to sell 115640 shares of Gilead common stock. These shares were acquired on 02/05/2026 via a stock option exercise from the issuer and are to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ exchange.

How were the 115640 Gilead shares in the Form 144 acquired?

The 115640 Gilead common shares were acquired on 02/05/2026 through a stock option exercise from the issuer. Payment for these shares was made in cash on the same date, according to the acquisition and payment information disclosed in the Form 144 filing.

What recent Gilead (GILD) share sales has Daniel O'Day reported?

Over the past three months, Daniel O'Day reported four sales of Gilead common stock: three sales of 10000 shares each and one sale of 115640 shares, on 11/28/2025, 12/29/2025, 01/23/2026, and 01/28/2026, with disclosed gross proceeds for each transaction.

What is the market value of the Gilead shares in this Form 144?

The Form 144 lists an aggregate market value of 17346000.00 for the 115640 Gilead common shares to be sold. This value appears in the securities information table alongside the planned sale amount and the number of Gilead shares reported as outstanding.

How many Gilead (GILD) shares are reported outstanding in the filing?

The Form 144 states that 1240679623 shares of Gilead common stock are outstanding. This outstanding share count appears in the securities information table and serves as a baseline context for the size of the 115640-share planned sale by Daniel O'Day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001638643
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	GILEAD SCIENCES, INC.
SEC File Number	000-19731
Address of Issuer	333 Lakeside Drive Foster City CALIFORNIA 94404
Phone	(650) 574-3000
Name of Person for Whose Account the Securities are To Be Sold	DANIEL O'DAY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	115640	17346000.00	1240679623	02/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/05/2026	Stock Option Exercise	ISSUER			115640	02/05/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	12/29/2025	10000	1248272.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	11/28/2025	10000	1265444.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	01/28/2026	10000	1398911.00
DANIEL O'DAY 333 Lakeside Drive Foster City CA 94404	Common	01/23/2026	115640	15611400.00

144: Remarks and Signature

Remarks
Date of Notice	02/05/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel P O'Day
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)